EUVIMEDEUVIMED entdecken
Crossref

Abstract 7396: Outcomes of Non-IVDU Right-Sided Infective Endocarditis: Surgery, Percutaneous Intervention, or Medical Management in a National Cohort

Bilal Islam, Sunia Shabir chaudhary, Rajan Shah, Dawood Shehzad, Hammad Chaudhry, Perry Wengrofsky

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.7396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Bilal Islam und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Right-sided infective endocarditis (RSIE) is uncommon in patients without a history of intravenous drug use (non-IVDU), and evidence guiding management - surgical intervention, percutaneous mechanical aspiration (PMA), or medical therapy - is limited. We aim to evaluate in-hospital mortality and outcomes among non-IVDU RSIE patients stratified by treatment approach, using a large, nationally representative cohort.

Methods

Using the National Inpatient Sample (2017-2022), adults with non-IVDU RSIE were identified using ICD-10 codes for IE and isolated right-sided valve involvement. Patients were categorized by treatment approach: surgery, PMA, or medical therapy. Survey-weighted logistic regression adjusted for demographics, hospital factors, and comorbidities.

Results

Among 22,075 weighted non-IVDU RSIE hospitalizations, surgery was performed in 1,205 patients (5.5%), PMA in 365 patients (1.7%), and medical therapy alone in 21,000 patients (92.8%). Weighted in-hospital mortality was lowest in the surgical group at 5.4% (95% CI 3.1-9.1%), intermediate for PMA at 8.2% (95% CI 3.7-17.2%), and highest in the medical therapy group at 12.8% (95% CI 11.8-13.9%). In multivariable logistic regression, medical therapy was associated with significantly higher odds of in-hospital death compared with surgery (OR 2.59, 95% CI 1.44-4.64, p=0.001), whereas PMA was not statistically different from surgery (OR 1.44, 95% CI 0.51-4.08, p=0.49). Other independent predictors of mortality included older age, ESRD, chronic liver disease, and prior heart failure.

Conclusions

Non-IVDU RSIE is rare but carries substantial in-hospital mortality. Surgical management is associated with the lowest mortality, PMA shows intermediate outcomes, and medical therapy alone carries the highest mortality. These findings support consideration of early intervention in eligible non-IVDU RSIE patients, while highlighting the need for further studies to define the role of PMA.

Zitieren

APA

Islam, B., chaudhary, S. S., Shah, R., Shehzad, D., Chaudhry, H., & Wengrofsky, P. (2026). Abstract 7396: Outcomes of Non-IVDU Right-Sided Infective Endocarditis: Surgery, Percutaneous Intervention, or Medical Management in a National Cohort. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7396

Vancouver

Islam B, chaudhary SS, Shah R, Shehzad D, Chaudhry H, Wengrofsky P. Abstract 7396: Outcomes of Non-IVDU Right-Sided Infective Endocarditis: Surgery, Percutaneous Intervention, or Medical Management in a National Cohort. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7396

BibTeX
@article{Islam2026,
  author = {Islam, Bilal and chaudhary, Sunia Shabir and Shah, Rajan and Shehzad, Dawood and Chaudhry, Hammad and Wengrofsky, Perry},
  title = {Abstract 7396: Outcomes of Non-IVDU Right-Sided Infective Endocarditis: Surgery, Percutaneous Intervention, or Medical Management in a National Cohort},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.7396}
}
Kostenlos starten →